(无标题)
Calling it now: Google/Isomorphic is going to start partnering/investing in/buying biopharma companies. Now that success rate on truly novel protein-molecule interactions is this high, it's a game of being given access to libraries of validated (but hitherto undruggable targets) https://t.co/QTgdUgTpDN